Search
for
Sort by
Research 331–360 of 1000+
- NEW PROPRIETARY BRANDS: Cephalexin
- New drugs: Agalsidase beta
- NEW FORMULATIONS: Sodium cromoglycate
- NEW FORMULATIONS: Glatiramer acetate
- Drug-Induced Hair Loss and Hair Growth
- Assessment, diagnosis and treatment of a patient with hirsutism
- Physiological Skin Changes During Pregnancy
- Primary Care of Adult Women
- Pharmacologic Treatment of Polycystic Ovary Syndrome
- Use of cyproterone acetate (CPA) in the treatment of acne, hirsutism and virilism
- Systematic approach to hair loss in women
- An updated review of the sebaceous gland and its role in health and diseases Part 2: Pathophysiological clinical disorders of sebaceous glands
- SYSTEMATIC REVIEW OF PHARMACOTHERAPY STRATEGIES IN THE MANAGEMENT OF HIDRADENITIS SUPPURATIVA
- Exploring Nanotechnology With Traditional Herbal Pharmacology: Nano Carrier-Based Phytochemical Delivery In PCOS Treatment
- Relative Safety and Efficacy of Finasteride for Treatment of Hirsutism
- Polycystic Ovary Syndrome and Its Differential Diagnosis
- Polycystic ovary syndrome: Pathophysiology, Symptoms, Risk factors, and Pharmacological treatment
- Ethinylestradiol/Chlormadinone Acetate for Use in Dermatological Disorders
- Exploring the therapeutic potential of phytochemicals apigenin and ellagic acid in managing polycystic ovarian syndrome and its comorbidities: a comprehensive review
- If Women Just had Their Hormones Back the Way they Were!
- Desideratum dermatologicum--cause and control of premenstrual acne flare
- Tinea Capitis: An Overview with Emphasis on Management
- A review on Hair Loss & Damage
- Skin manifestations of hyperandrogenism: an update
- Current systemic treatment strategies for hidradenitis suppurativa
- Polycystic ovary syndrome
- Unwanted hair.
- Drug Reactions Affecting Hair: Diagnosis
- Recent advances in microneedle composites for biomedical applications: Advanced drug delivery technologies
- Polycystic Ovarian Syndrome: Long-Term Health Consequences